Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
6,322,223
-
Share change
-
-253,362
-
Total reported value
-
$5,960,890
-
Put/Call ratio
-
1.7%
-
Price per share
-
$0.9400
-
Number of holders
-
20
-
Value change
-
-$246,043
-
Number of buys
-
4
-
Number of sells
-
9
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q1 2023
As of 31 Mar 2023 Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,322,223 shares of stock of the company.
Largest 10 holders included HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, STONEHILL CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, Whitefort Capital Management, LP, Aristides Capital LLC, ENVESTNET ASSET MANAGEMENT INC, MORGAN STANLEY, Atria Wealth Solutions, Inc., and WEALTHSOURCE PARTNERS, LLC.
This table shows 20 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.